Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy

J Neurol. 2024 May;271(5):2871-2874. doi: 10.1007/s00415-023-12175-2. Epub 2024 Jan 11.

Elisabeth Maillart¹, Eve Todesco², Lambert Assoumou³, Ysoline Beigneux⁴, Catherine Lubetzki⁴, Caroline Papeix^{4

5}, Raphael De Paz⁴, Anne-Laure Dubessy⁶, Siham Djebara⁷, Céline Louapre^{4

8}, Valérie Pourcher^{3

7}

¹ Department of Neurology, AP-HP, Hôpital Pitié-Salpêtrière, Multiple Sclerosis Center, Paris, France. elisabeth.maillart@aphp.fr.
² Department of Virology, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
³ Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), Sorbonne Université, INSERM, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Paris, France.
⁴ Department of Neurology, AP-HP, Hôpital Pitié-Salpêtrière, Multiple Sclerosis Center, Paris, France.
⁵ Neurology Department, Hospital Foundation A. De Rothschild, 75019, Paris, France.
⁶ Department of Neurology, AP-HP, Hôpital Saint-Antoine, Multiple Sclerosis Center, Paris, France.
⁷ Infectious and Tropical Diseases Department, Sorbonne University, AP-HP, Pitié-Salpêtrière Hospital, 75013, Paris, France.
⁸ Clinical Investigation Centre, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, 75013, Paris, France.

No abstract available

Publication types